Phase 3 trial for oral cUTI antibiotic stopped early for efficacy Chris Dall, MA
Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral antibiotic for complicated urinary tract infections (cUTIs) was stopped early for efficacy. The PIVOT-PO trial was stopped after…








